New hope for men with aggressive prostate cancer that stopped responding to treatment

NCT ID NCT06780670

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing an experimental drug called AAA817 against standard treatments for men with advanced prostate cancer that has spread and stopped responding to hormone therapy, chemotherapy, and a specific type of targeted radiation therapy. The goal is to see if AAA817 can better control the cancer's growth and help patients live longer. The trial will involve about 443 adult men whose cancer shows a specific marker (PSMA) and has progressed despite previous treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-••••

Locations

Associated Med Professionals of NY
RECRUITING

Syracuse, New York, 13210, United States

Contact Email: •••••@•••••

Contact
Dana Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02115, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Indiana University
RECRUITING

Indianapolis, Indiana, 46202, United States

Contact Email: •••••@•••••

Contact
Medical College Of Wisconsin
RECRUITING

Milwaukee, Wisconsin, 53226, United States

Contact

Contact Email: •••••@•••••
Nebraska Cancer Specialists
RECRUITING

Omaha, Nebraska, 68154, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Novartis Investigative Site
RECRUITING

Darlinghurst, New South Wales, 2010, Australia
Novartis Investigative Site
RECRUITING

Herston, Queensland, 4029, Australia
Novartis Investigative Site
RECRUITING

São Paulo, São Paulo, 01308-050, Brazil
Novartis Investigative Site
RECRUITING

São Paulo, São Paulo, 05652-000, Brazil
Novartis Investigative Site
RECRUITING

Fuzhou, Fujian, 350025, China
Novartis Investigative Site
RECRUITING

Wuhan, Hubei, 430022, China
Novartis Investigative Site
RECRUITING

Wuhan, Hubei, 430030, China
Novartis Investigative Site
RECRUITING

Nanjing, Jiangsu, 210006, China
Novartis Investigative Site
RECRUITING

Nanjing, Jiangsu, 210029, China
Novartis Investigative Site
RECRUITING

Shenyang, Liaoning, 110011, China
Novartis Investigative Site
RECRUITING

Xian, Shanxi, 710032, China
Novartis Investigative Site
RECRUITING

Xian, Shanxi, 710061, China
Novartis Investigative Site
RECRUITING

Chengdu, Sichuan, 610041, China
Novartis Investigative Site
RECRUITING

Beijing, 100034, China
Novartis Investigative Site
RECRUITING

Beijing, 100036, China
Novartis Investigative Site
RECRUITING

Guangzhou, 510060, China
Novartis Investigative Site
RECRUITING

Shanghai, 200025, China
Novartis Investigative Site
RECRUITING

Shanghai, 200032, China
Novartis Investigative Site
RECRUITING

Tianjin, 300308, China
Novartis Investigative Site
RECRUITING

Hong Kong, 999077, Hong Kong
Novartis Investigative Site
RECRUITING

Beersheba, 8457108, Israel
Novartis Investigative Site
RECRUITING

Haifa, 3109601, Israel
Novartis Investigative Site
RECRUITING

Petah Tikva, 4941492, Israel
Novartis Investigative Site
RECRUITING

Ramat Gan, 5265601, Israel
Novartis Investigative Site
RECRUITING

Tel Aviv, 6423906, Israel
Novartis Investigative Site
RECRUITING

Kashiwa, Chiba, 2778577, Japan
Novartis Investigative Site
RECRUITING

Sapporo, Hokkaido, 0608648, Japan
Novartis Investigative Site
RECRUITING

Kobe, Hyōgo, 6500047, Japan
Novartis Investigative Site
RECRUITING

Yokohama, Kanagawa-ku, 236-0004, Japan
Novartis Investigative Site
RECRUITING

Chiba, 260-8717, Japan
Novartis Investigative Site
RECRUITING

Fukuoka, 812-0033, Japan
Novartis Investigative Site
RECRUITING

Fukuoka, 8128582, Japan
Novartis Investigative Site
RECRUITING

Fukushima, 9601295, Japan
Novartis Investigative Site
RECRUITING

Ishikawa, 9208641, Japan
Novartis Investigative Site
RECRUITING

Kyoto, 6068507, Japan
Novartis Investigative Site
RECRUITING

Singapore, 119228, Singapore
Novartis Investigative Site
RECRUITING

Singapore, 168583, Singapore
Novartis Investigative Site
RECRUITING

Singapore, 258499, Singapore
Novartis Investigative Site
RECRUITING

Seoul, Korea, 03080, South Korea
Novartis Investigative Site
RECRUITING

Seoul, 05505, South Korea
Novartis Investigative Site
RECRUITING

Bern, 3010, Switzerland
Novartis Investigative Site
RECRUITING

Taipei, 10002, Taiwan
Novartis Investigative Site
RECRUITING

Taipei, 103616, Taiwan
Novartis Investigative Site
RECRUITING

Taipei, 11217, Taiwan
Novartis Investigative Site
RECRUITING

Taoyuan District, 33305, Taiwan
University Cancer and Blood Center LLC
RECRUITING

Athens, Georgia, 30607, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
University of Kansas Hospital
RECRUITING

Kansas City, Kansas, 66160, United States

Contact Email: •••••@•••••

Contact
VA Greater LA Healthcare System
RECRUITING

Los Angeles, California, 90073, United States

Contact

Contact Email: •••••@•••••
WA Uni School Of Med
RECRUITING

St Louis, Missouri, 63110, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER